- Home
- SENEB vs DNA Comparison
SENEB vs DNA Comparison
Compare SENEB & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENEB
- DNA
- Stock Information
- Founded
- SENEB 1949
- DNA 2008
- Country
- SENEB United States
- DNA United States
- Employees
- SENEB N/A
- DNA N/A
- Industry
- SENEB Packaged Foods
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SENEB Consumer Staples
- DNA Health Care
- Exchange
- SENEB Nasdaq
- DNA Nasdaq
- Market Cap
- SENEB 436.7M
- DNA 423.5M
- IPO Year
- SENEB N/A
- DNA N/A
- Fundamental
- Price
- SENEB $63.00
- DNA $6.37
- Analyst Decision
- SENEB
- DNA Hold
- Analyst Count
- SENEB 0
- DNA 6
- Target Price
- SENEB N/A
- DNA $37.80
- AVG Volume (30 Days)
- SENEB 1.8K
- DNA 1.2M
- Earning Date
- SENEB 11-26-2024
- DNA 11-12-2024
- Dividend Yield
- SENEB N/A
- DNA N/A
- EPS Growth
- SENEB 23.82
- DNA N/A
- EPS
- SENEB 5.83
- DNA N/A
- Revenue
- SENEB $1,482,656,000.00
- DNA $217,951,000.00
- Revenue This Year
- SENEB N/A
- DNA N/A
- Revenue Next Year
- SENEB N/A
- DNA $12.85
- P/E Ratio
- SENEB $11.26
- DNA N/A
- Revenue Growth
- SENEB N/A
- DNA N/A
- 52 Week Low
- SENEB $45.00
- DNA $5.26
- 52 Week High
- SENEB $65.30
- DNA $75.20
- Technical
- Relative Strength Index (RSI)
- SENEB 53.77
- DNA 33.79
- Support Level
- SENEB $62.16
- DNA $8.13
- Resistance Level
- SENEB $64.36
- DNA $10.07
- Average True Range (ATR)
- SENEB 1.10
- DNA 0.70
- MACD
- SENEB -0.08
- DNA -0.14
- Stochastic Oscillator
- SENEB 41.33
- DNA 8.87
About SENEB Seneca Foods Corp. Class B
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.